SCHEMBL6714540

SCHEMBL6714540

O=S(=O)(c1ccc(Br)cc1)N(c1ccccc1)C(CCc1ccccc1)C1CCCNC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 7/20 0.37
PSEN2 P49810 7/20 0.37
APH1B Q8WW43 7/20 0.37
NCSTN Q92542 7/20 0.37
APH1A Q96BI3 7/20 0.37
PSENEN Q9NZ42 7/20 0.37
TAS2R14 Q9NYV8 1/20 0.35
RAB9A P51151 1/20 0.34
ESR1 P03372 2/20 0.33
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
CYP2D6 P10635 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710676 0.85 SCN9A (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6290237 0.82 HTR6 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7529516 0.77 HTR6 (0.45) MEN1KMT2AMAPTCYP2D6ALDH1A1
SCHEMBL7492223 0.72 HTT (0.39) MEN1HTTKMT2ASLC6A2SLC6A4
SCHEMBL7498243 0.71 OPRD1 (0.44) KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL7503837 0.71 OPRD1 (0.44) KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL5871033 0.71 OPRD1 (0.44) KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL7497373 0.71 SLC6A2 (0.41) KMT2ACYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL6290220 0.70 SLC6A2 (0.46) CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL6499006 0.69 EPHX2 (0.36) RAB9AMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040235832-A1 ANTIPSYCHOTIC SULFONAMIDE-HETEROCYCLES, AND METHODS OF USE THEREOF WU XINHE (US) 2004-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235832-A1 ANTIPSYCHOTIC SULFONAMIDE-HETEROCYCLES, AND METHODS OF USE THEREOF TRPV1, CNR2, TRPM5 PSEN1 1522/4885PSEN2 1197/4885APH1B 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.